目錄：第一章貨幣與貨幣制度第二章信用與利率第三章金融機(jī)構(gòu)業(yè)務(wù)與管理第四章金融市場(chǎng)與金融創(chuàng)新第五章金融監(jiān)管與貨幣政策調(diào)控第1題OnestudyaimedtostudytheassociationofHelicobacterpyloriinfectionandriskofgastriccancer.Theresearchersrecruited500newly-diagnosedgastriccancerpatientsand1000ageandgendermatchednon-cancerindividuals.ThentheresearchersmeasuredtheIgGantibodyofHelicobacterpyloriandtestedwhetherthestatus(positivevsnegative)ofHelicobacterpyloriwasassociatedwiththeriskofgastriccancer.Whatisepidemiologicaldesignofthisstudy?()ACross-sectionalstudyBCase-controlstudyCCohortstudyDClinicaltrialEEcologicalstudy第2題OnestudyaimedtostudytheassociationofHelicobacterpyloriinfectionandriskofgastriccancer.Theresearchersrecruited1000volunteerswithoutgastriccancerandmeasuredtheIgGantibodyofHelicobacterpylori.Thentheresearchersfollowed-upperiodicallythevolunteersfor10yearsandrecordedthecasesofgastriccancer.Afterthefollowing-up,researcherstestedwhetherthebaselinestatus(positivevsnegative)ofHelicobacterpyloriwasassociatedwiththedevelopmentofgastriccancer.Whatisepidemiologicaldesignofthisstudy?()ACross-sectionalstudyBCase-controlstudyCCohortstudyDClinicaltrialEEcologicalstudy第3題OnestudyaimedtostudywhethereradicationofHelicobacterpyloricouldreducetheriskofgastriccancer.Theresearchersrecruited2000Helicobacterpylori–positivevolunteerswithoutgastriccancer,andthengroupedthemrandomlytotheinterventiongroup(receivingtreatmentofHelicobacterpylori)andtothegroupwithouttreatment.Thentheresearchersfollowed-upthevolunteersperiodicallyfor10yearsandrecordedthecasesofgastriccancer.Afterthefollowing-up,researcherstestedwhetherthebaselineinterventionwasassociatedwiththedevelopmentofgastriccancer.Whatisepidemiologicaldesignofthisstudy?()ACross-sectionalstudyBCase-controlstudyCCohortstudyDExperimentaltrialEEcologicalstudy第4題OnestudyaimedtostudythedistributionofHelicobacterpyloriinfectioningeneralpopulation.Theresearchersselectedthesubjectsincommunitiesofonedistrictusingaprobability-basedsamplingdesign,andmeasuredtheinfectionstatusofHelicobacterpylori.Whatisepidemiologicaldesignofthisstudy?()ACross-sectionalstudyBCase-controlstudyCCohortstudyDClinicaltrialEEcologicalstudy第5題OnestudyaimedtostudytheassociationofHelicobacterpyloriinfectionandriskofgastriccancer.Theresearchersrecruitednewly-diagnosedgastriccancerpatientsandnon-cancercontrolsandthendeterminedthestatus(positivevsnegative)ofHelicobacterpylori.Theyfoundthatcomparingtothecontrols,HelicobacterpylorihasanOR1.8(P<0.05).Whichofthefollowingsisnottrue?()AThepositiverateofHelicobacterpyloriishigherinthegastriccancergroup.BHelicobacterpyloriisassociatedwith1.8timeshigherriskofgastriccancer.CHelicobacterpyloriisariskfactorforgastriccancer.DThecontrolgrouphashigherriskofHelicobacterpylori.EThisisacasecontrolstudydesign.第1題Whatarethetopthreemodifiableriskfactorsfordevelopingcancer?()ATobaccouse,excessbodyweight,alcoholintakeBTobaccouse,sun/UVexposure,alcoholuseCTobaccouse,cancer-causingpathogens,physicalinactivityDTobaccouse,sun/UVexposure,excessbodyweightETobaccouse,physicalinactivity,sun/UVexposure第2題Themostrecentestimateisthat13percentofallnewcancercasesdiagnosedworldwidewereattributabletopersistentinfectionwithpathogens.Whichofthefollowingisthemostcommoncancer-causingpathogen?()AHelicobacterpyloriBHepatitisBvirus(HBV)CHepatitisCvirus(HCV)DHumanpapillomavirus(HPV)EAlloftheabove正確答案：E第3題Changingormodifyingcertainbehaviorscanreduceriskfordevelopingcancer.Whichofthefollowinglifestylemodificationscanreduceriskofcancer?()AStayphysicallyactiveBLimitconsumptionofredmeatandprocessedfoodsCMaintainahealthy(lean)weightDLimitalcoholconsumptionEAlloftheabove正確答案：E第4題Whatis

not

asignificantfactorincreasingthelikelihoodofdevelopingovarianandbreastcancers?()ABRAC1orBRAC2mutationsBHavingachildaftertheageof30CSmokingDHormonereplacementtherapyEBeingoverweightfollowingmenopause第5題A39-year-oldwomancomestothephysicianbecauseofmildclumsinesswhenwalking,tinglinginherhandsandfeet,andpersistentfatigue.Shestatesthatshemaintainsthesamebalanceddiet.Hertemperatureis36.9°C(98.4°F),pulseis80beatsperminute,respirationsare14aminute,andbloodpressureis128/76mmHg.Physicalexaminationshowsasmooth,redtonguewithlossofpapillae,mildgaitdisturbance,andimpairedpositionsenseandvibrationperception.Laboratorytestsshowanerythrocytecountof3.0million/mm3,hemoglobinof10g/dL,hematocritof30%,andMCVof125mum3.Serumfolatelevelisnormalandserummethylmalonicacidiselevated.OralvitaminabsorptionstudiesdemonstratethatthepatientisunabletoabsorbvitaminB12

inadequateamountswithoutaddedintrinsicfactor.Thispatient'sconditionisassociatedwithanincreasedriskofdevelopingcancerofwhichofthefollowingorgans?()AColon.BDuodenum.CEsophagus.DIleum.EStomach.正確答案：EMolecularmechanismsoftumorigenesistask第1題Whichofthefollowingisnotaninactivationmechanismoftumorsuppressorgenes:()AGenemutationBLossofheterozygosityCGeneamplificationDEpigeneticabnormalities第2題Whichofthefollowingisnotaconsequenceofgeneamplification?()AExcessiveDNAreplicationBGenemutationCGenecopynumberincreaseDProteinencodedincrease第3題Chromosometranslocationcanmakeaproto-oncogeneunderthecontrolof:()AAstrongpromoterBAnintronCAnexonDAnenhancer第4題The3stepsofsignaltransductioninorderare()AReception,Transduction,ResponseBResponse,Reception,TransductionCTransduction,Reception,ResponseDTransduction,Response,Reception第5題WhichofthefollowingplaysakeyroleinaberrantactivationofPI3K-AKTsignalingpathway:()ADeletionofPI3KCABAmplificationofEGFRCAmplificationofPTENDMutationofPDK1第6題Whichofthefollowingstatementisincorrect:()AThecoreelementofsignalingpathwaycontainsligand,receptor,transductionmolecule,andtranscriptionfactorBCancercellsacquirenovelsignalingpathwaystomaintaintheirconstantproliferationCVarioussignalscanbetransducedthroughthesamedownstreameffectorDOnesignalisusuallytransducedthroughmultipledownstreameffectorsBiologicalbehavioroftumorigenesistask第1題Whichofthefollowingisnotpro-angiogeniccytokines:()AVascularendothelialcellgrowthfactor(VEGF)BAngiogenin(Ang)CFibroblastgrowthfactors(FGF)DMatrixmetalloproteinase(MMP)EInterferon(INF)正確答案：E第2題What’sthemechanismofVEGFparticipateinthewholeprocessoftumorgrowth,choosethebestanswer?()APromoteangiogenesisBFormabnormalvesselsCIncreasevascularpermeabilityDPromotemetastasisEAlloftheabove正確答案：E第3題Whatarethemainfeaturesofmalignanttumors?()AInvasionandmetastasisBInfiniteproliferationandexfoliationCWarburgeffectandangiogenesisDImmuneescapeandarrestedapoptosisEGenomeinstabilityandmutation第4題Whatisnecessaryatthebeginningandendoftumormetastasis:()AAngiogenesisBEnterthecirculatorysystemCShedandinvadedintothematrixDTumorthrombusformationETumorcellsgrowatthesecondarysites第5題Cyclinisassociatedwith___________()ALeptospirosisBGlycolysisCCytosisDMitosisENoneoftheabove第6題Cdksbindwith__________,enablingtheCdkstofunctionasenzymes.AMPFBCyclinsCHistonesDP53EEF1第7題Whichofthefollowingisnottumorsuppressorprotein?()AP53BP16CBCL2DRbEAPC第8題Whichofthefollowingphasesismostsensitivetoradiotherapy？AG0BG1/S

CG1DSEG2/M正確答案：ETumormarkerdiagnosistask第1題Theroleoftumormarkersdoesnotinclude()AJudgementoftumorprognosisBIndividualizedtreatmentoftumorCEarlydetectionoftumorDMonitoringoftumortreatmentefficacyEDiagnosticindicatorsoftumor正確答案：E第2題Whichofthefollowingistheindicatortoguidethemoleculartargetedtherapyofbreastcancer()ACEABEGFRCHer-2DK-RASEALK第3題Whichofthefollowingisnotacharacteristicofanidealtumormarker()AGoodorganspecificityBHighsensitivityCEasytodetectDLonghalf-lifeEItisrelatedtothemalignantdegreeandprognosisofthetumor第4題Whichofthefollowingtumormarkersisoftenusedforbreastcancer()ACA153BPSACNSEDCA72-4EAFP第5題Whichofthefollowingtumormarkerscanguidetheendocrinetherapyofbreastcancer（）ABRAFBER、PRCEGFRDCA153EHer-2第6題Whichofthefollowinggenemutationspredictsanincreasedriskofbreastcancer（）AHer-2BKRASCBRCA1、BRCA2DEGFREER、PRPathologicaldiagnosisoftumortask第1題Generallywenamethebenigntumorswithhistologicaloriginplus–oma,exceptfor_____().AAdipomaBFibromaCAdenomaDMelanomaELeiomyoma第2題WhichofthefollowingisNOTture?

(___)ABenigntumorscanchangeintomalignanttumors.BMalignanttumorscanstoptogrowwithoutanyintervention.CAccordingtodifferentiation,atypia,mitosis,etc.wegradetumorsintowelldifferentiated,moderatedifferentiatedandpoordifferentiated.DNomenclatureoftumorscancombineclinical,pathologicalmorphologic,immunohistochemicalphenotypicalandmoleculargeneticcharacteristics.ETumorscanbeclassifiedintobenign,borderlineandmalignantaccordingtothecharactersandharmtothehumanbody.第3題Thetumorswhosenamesendedwith–blastomausuallyaremalignant,exceptfor_____().ANeuroblastomaBOsteoblastomaCHepatoblastomaDRetinoblastomaENephroblastoma第4題Whichofthefollowingplaysakeyroleindifficultiesofpathologicaldiagnosis?(___)ASpecimenBFixationCDissectionDDiagnosticexperienceEAlloftheabove正確答案：E第5題A3-year-oldfemalepatientwasadmittedinthehospitalforpresenceofabdominalmass(maximumdiameter:10.5cm).Initialbiopsypathologicaldiagnosiswasganglioneuroma.However,afterexcisionofabdominalmassfinaldiagnosisbecameganglioneuroblastoma.Whichofthefollowingshouldberesponsibleforthesituation?(___)()AThelimitationofbiopsyspecimenBThebiopsyspecimenisnotwellfixed.CThepathologicalmedicianislackofdiagnosticexperienceDTumorheterogeneityEThelesionstillhasnotprogresstothetypicalmorphorlogy.Imagingdiagnosisoftumortask第1題Keypointsforclinicaldiagnosisofprimarylivercancer,thefollowingoptionsarenotincluded:()AHistoryofHBVorHCVBHepaticmassCAFP>400ug/lfor1monthorAFP>200ug/lfor2monthsDAbdominalvarices,splenomegalyEImagingevidenceofB-ultrasoundandCTexamination第2題WhichoftheCTfindingsofprimarylivercanceriswrong:()AEnhancedscanshowedobviousenhancementinvenousphaseBMostoftheplainscanswerelow-densityfociCEnhancedscanningshowedobviousenhancementinarterialphaseDLocallivercontourmaybeconvexEWithcirrhosisandsplenomegaly第3題WhichiswrongabouttheconceptofCTplainscanforlivercancer:()AMostlesionswerelowdensityBInfattyliverorcirrhosis,thedensitydifferencebetweentheliverandthefocusdecreasesCThebetterthedifferentiationoftumorcells,thegreaterthedifferencebetweentheirdensityandthatofnormalliverDWithnecrosis,hemorrhageandcalcificationEWhenfattyliverisparticularlyprominent,thelesionbecomeshigherdensity第4題MRIfindingsofnormallivercancer:()AThesignalofT1weightedimageishigherthanthatofspleen,andthesignalofT2weightedimageislowerthanthatofspleenBThesignalofT1weightedimageislowerthanthatofspleen,andthesignalofT2weightedimageishigherthanthatofspleenCT1andT2weightedimagesignalswerehigherthanthoseofspleenDT1andT2weightedimagesignalswerelowerthanthoseofspleenET1andT2weightedimagesignalsweresimilartothoseofspleen第5題Whichofthefollowingiswronginangiographicfindingsofprimarylivercancer:()ACompressionanddisplacementofpericancerousarteriesBNeovascularizationandtumorstainingCPortalveininvasionandtumorthrombusformationDOcclusionofbloodsupplyarteryEArteriovenousfistulaClinicalDiagnosisandtreatmentevaluationoftumorstask第1題Whichofthefollowingstatementsisfalse?()ATheTNMstagingsystemhasbeenwidelyusedintheevaluationofhematologicaltumors.BTNMstagingcriteriaaredifferentindifferenttumors.CTheTstagingrepresentsthesizeofthetumour.DTheNstagingrepresentsthelymphnodeinvasion.ETheMStagingrepresentsthemetastasisoftumour.第2題()representsfailuretoassesstheprimarytumor.ATxBTisCT0DT1ET2第3題Whichofthefollowingstatementsistrue?()ARelapsestagingshouldbeestablishedbeforethebeginningofanyanticancertreatmentandshouldnotbealteredbasedonanydataobtainedaftertreatment.BClinicalstagingisbasedontheevidenceobtainedbeforetheinitialtreatment.CClinicalstagingissupplementedandrevisedaccordingtootherevidenceobtainedfromsurgery(especiallyevidencefrompathologicaldiagnosis).DPathologicalstagingismoreimportantthanclinicalstagingandhasreplacedclinicalstagingintheevaluationoftumourtreatment.EClinicalstagingisbasedontheevidenceobtainedaftertheinitialtreatment.第4題Whichofthefollowinglesionismeasurable?()ApericardiumascitesBLeptomeningealmetastasisCInflammatorylymphaticmetastasisinskinorlungDFusionnodes.第5題Therequirementsformeasurement,except:()AThebaselinetimeshouldbeclosetothebeginning,lessthan4weeks.BForthesamelesion,thesameexaminationmethodwasusedatbaselineandfollow-up.CTendtothesamemeasuringphysician.DNumber:eachorgan≤2,total≤10.第6題Howtodefineprogressiondisease?()AAtleasta20%increaseinthesumofdiametersoftargetlesionscomparedwithminimum,thesummustalsodemonstrateanabsoluteincreaseofatleast5mm.Orappearanceofnewlesions.BAtleasta20%increaseinthesumofdiametersoftargetlesionscomparedwithbaseline,thesummustalsodemonstrateanabsoluteincreaseofatleast5mm.Orappearanceofnewlesions.CAtleasta20%increaseinthesumofdiametersoftargetlesionscomparedwithminimum,thesummustalsodemonstrateanabsoluteincreaseofatleast10mm.Orappearanceofnewlesions.DAtleasta20%increaseinthesumofdiametersoftargetlesionscomparedwithbaseline,thesummustalsodemonstrateanabsoluteincreaseofatleast10mm.Orappearanceofnewlesions.Comprehensivetherapyandindividualtherapyoftumor第1題Whichofthefollowingstatementsisincorrect:()AMolecularmarkersmainlyincludeprognosticandpredictivemolecularmarkersBPrognosticmarkersareassociatedwithdiseaseoutcomeCPrognosticmarkersarerelatedtotherapeuticdrugsandotherinterventionsDPredictivemarkersarefactorsthatcanjudgetheprobabilityoftreatmenteffectEPredictivemarkersarerelatedtotherapeuticdrugsandotherinterventions第2題Themostcommontargetofnon-smallcelllungcanceris:()AHER2BEGFRCBCR/ABLDBRAFV600EEKIT第3題Thebasicprincipleofcancercomprehensivetreatment:()APayingequalattentiontobothlocalandwholebody,costandeffect,andsurvivalandqualityoflifeBTreatmentbystagesCIndividualizedtreatmentDWholeprocessmanagementEAlltheabove正確答案：E第4題Themosteffectivelocaltreatmentforcanceris:()ARadiotherapyBSurgicaltreatmentCVascularinterventionaltherapyDNon-vascularinterventionaltherapyEOthertreatment第5題Themostwidelyusednon-surgicalcomprehensivetreatmentmodeforcanceris:()ASequentialtherapyBSimultaneoustherapyCAlternativetherapyDTraditionalChinesemedicineERehabilitationandpalliativetreatment第6題Whichofthefollowingisnotcommonlyusedasanembolizationagent:()ADoxorubicinBSpringcoilCGelatinSpongeDPVAparticlesEIodizedoil第7題ForTACE,themostcommonarterytopunctureis()AFemoralveinBFemoralarteryCIliacarteryDIliacveinE.Thehepaticartery第8題WhichofthefollowingisnotanindicationforTACEsurgery()AThemainportalveinisnotcompletelyobstructedBThegoalofpreoperativetreatmentistoshrinkthetumorforsecondarysurgeryCLiverfunctionisinChildCDThepatientcannotbeexcisedforvariousreasonsordoesnotreceivesurgicaltreatmentEPostoperativerecurrence正確答案：ESurgicaltreatmentoftumortask第1題InWhipple’soperation,weneedtoremovethefollowingorgans,except()ADuodenalruptureBTheGDACHelendidDSpleenEBileduct第2題IfICGR15between10%and19%,()A4segmentsofliveraretoleratedBonly1segmentofliveristoleratedC2or3segmentsofliveraretoleratedDonlytumorenucleationElocalizedminorhepatectomy第3題Surgeryisthemosteffectivetreatmentforsolidtumors,()%ofthetumorsweretreatedsurgicallyA10B20C30D60E90第4題Whichbloodvesseldoesnotcomefromtheabdominaltrunk()ASplenicarteryBLefthepaticarteryCRighthepaticarteryDGDAEPortalvein正確答案：E第5題WhoneedstoacceptWhipple’soperation()ALungCancerBLiverCancerCRectalCancerDPancreaticheadcancerEEsophagealCancerRadiationoncologytask第1題TheyearwhenRoentgendiscoveredX-raysis:()A1885B1886C1898D1895E1902第2題TheyearwhenMarieCuriediscoveredradiumis:()A1885B1886C1897D1895E1902正確答案：E第3題Theconventionalfractionateddoseofradiotherapyis:()A3.5-4.0Gy

B1.5-1.8GyC1.0-1.2GyD2.8-3.0GyE1.8-2.0Gy

正確答案：E第4題ThemostimportanttargetofX-raykillingcellsis:()ADNABRNACCellmembranesDMitochondriaEProteins第5題Themostsensitivecellcyclephasetoradiationis:()AG0BG1CG2/MDSESameradiosensitivityforallphasesabove第6題Whichofthefollowingoptionsisnotpartofthe"4Rs"theoryofradiobiology:()ARadiationdamageBRedistributionofcellcycleCReoxygenationofhypoxiccellsDApoptosisafterirradiationERepopulationofcellsChemotherapyoftumortask第1題WhichofthefollowingdrugisanRNA-blockingdrug：（）APlatinumBDaunorubicinCCyclophosphamide

DIrinotecanEGemcitabine第2題Whichofthefollowingisacommonlong-termtoxicsideeffectofchemicaldrugs:()AMyelosuppressionBGastrointestinalreactionsCAlopeciaDSecondarytumorsENeurotoxicity第3題Whichofthefollowingisnottheapplicationprinciplesofchemotherapydrugs:()AAppropriatemedicationtimeBMaximumdrugdoseCMulti-cycletherapyDCombinationchemotherapyEAppropriateadministrationroute第4題Whichofthefollowingdrugexertsantitumoreffectsbyinhibitingtopoisomerase:()AEtoposideBVincristineCPaclitaxelDDocetaxelEPlatinum第5題WhichofthefollowingdrugactsontheG1phaseofthecellcycle:()AAsparaginaseBFluorouracilCEtoposideDVinblastineEPaclitaxel第6題Nauseaand/orvomitingareadverseside-effectsofcancerchemotherapeuticdrugsinadult.Nauseaandvomitingarenotonlyexperiencedasposttreatmentsymptomsafterchemotherapy.Inwhichsubgroupofvomitingtypes,thesesymptomsalsooccurpriortoachemotherapeuticdruginfusion.()AAcutevomitingBDelayedvomitingCAnticipatoryvomitingDBreakthroughvomitingERefractoryvomiting第7題AccordingtoCommonTerminologyCriteriaforAdverseEvents(CTCAE）v5.0,whichofthefollowingisagrade3adversereaction.()ANeutrophils＜500/microLBPlatelets25,000/microLto50,000/microLCHemoglobins8.0to10.0g/dLDNeutrophils＜500/microLwithasingletemperature＞38.5℃EPlatelets＜25,000/microLInterventionaltherapyoftumortask第1題Whichofthefollowingtypesbelongstolocalablationtherapy,except：()Amicrowaveablation(MWA),

Btrans-arterialchemoembolization(TACE)Cpercutaneousethanolinjection(PEI)Dhigh-intensityfocusedultrasoundablation(HIFU)Efrequencyablation(RFA)第2題Themostcommonlyusedguidancemethodformicrowaveablationtherapyis（）ACTBMRICUSDECG

EPET-CT第3題Aftermicrowaveablation,thegrosspathologicappearanceoftreatedtissueshouldbereferredto()ACaseousnecrosisBLiquefactionnecrosisCHydropicdegenerationDFattydegenerationECoagulationnecrosis正確答案：EBiotherapyoftumortask第1題Whichofthefollowingdoesnotfallwithinthescopeofbiotherapyforcancer:()AImmunotherapyBTargetedtherapyCRadiationtherapyDEndocrinetherapyEGenetherapy第2題Whichofthefollowingisnotabiologicalreactionregulator:()ACytokinesBCisplatinCTNF-αinhibitorsDMonoclonalantibodyEApatinib第3題Whichofthefollowingisnotspecificimmunotherapy:()ATumorvaccineBRituximabmonoclonalantibodyCTILtherapyDNKcelltherapyECAR-Ttreatment第4題Whichofthefollowingdrugshastheeffectofinducingdifferentiation:()AArsenictrioxideBBortezomibCCetuximabDTamoxifenEInterleukin第5題Whichofthefollowingdrugsisnotamoleculartargetedtherapy:()ATrastuzumabBIcotinibCColonystimulatingfactorDImatinibEBevacizumabTargetedtherapyoftumortask第1題Whichofthefollowingdrugsisnotmoleculartargetedtherapydrug?ACetuximabBBevacizumabCTrastuzumabDPembrolizumabEGefitinib第2題Whichofthefollowingdrugsisasmallmoleculetargeteddrug?ABevacizumabBPertuzumabCSorafenibDRituximabEPanitumumab第3題Whichofthefollowingdrugsdon‘tbelongtyrosinekinaseinhibitors?AgefitinibBsunitinibCdasatinibDbevacizumabEsorafenib第4題Whichofthefollowingdrugismoleculartargetedtherapydrug?APanitumumabBBevacizumabCTrastuzumabDGefitinibEAllabove正確答案：E第5題Whichmechanismistargetingtumorgrowthmicroenvironment?ACellepigeneticsBAnti-angiogenesisCApoptosisfactorsDIntracellularsignaltransductionmoleculesEGrowthfactorreceptorsandcellmembranedifferentiationantigensonthecellmembraneImmunotherapyofcancertask第1題Themainmechanismofanti-tumorimmunityis()ANon-specificanti-tumoreffectofNKcellsBAntitumoreffectofnon-specificimmunecomponentsinbodyfluidsCCellularimmunityDHumoralimmunityETumorkillingeffectofTILandLAKcells正確答案：E第2題Antitumormechanismsofantibodiesdonotinclude()ACDCBADCCCOpsonizationDAntibodiesblockcertainreceptorsontumorcellsEBlockingtheeffectofcytokines正確答案：E第3題Whichofthefollowingisnotconsideredpassiveimmunotherapyfortumors()ADNAvaccineBTNFCTILcellDExogenousimmuneeffectorENKcell第4題ThefollowingsaredescriptionsofNKcellkilling,whichiswrong()ALackspecificityBDirecttumorkillingwithoutprioractivationCAntibody-dependentkillingoftumorsbyADCCDComplement-dependentkillingoftumorsbyCDCENoMHCrestriction第5題Whichofthefollowingisnotintendedtotreatcancerthroughregulatingtheimmunesystem:()AEnhancesimmunityagainsttumorBSuppressimmunosuppressivecheckpointsCImprovingtumorsuppressivemicroenvironmentDBreakingimmunetoleranceEBlockingTcellactivationbytargetingcostimulatorymolecule正確答案：E第6題Toavoidoveractivation,whichofthefollowingmoleculescanTcellsexpress:()APD-1BPD-L1CTCRDMHC-IIEICOS第7題Whichofthefollowingisnotanimmunecheckpointinhibitor:()APD-1antibodyBPD-L1antibodyCCTLA-4antibodyDCD20antibodyENKG2Aantiboy第8題Whichofthefollowingisnotacommonsideeffectofimmunecheckpointinhibitors:()AEnteritisBHypophysitisCSkinRashDVitiligoETumorlysissyndrome正確答案：E第9題Whichofthefollowingistumor-specificphenomenawithimmunecheckpointinhibitors:()APrimarydrugresistanceBAcquireddrugresistanceCSuper-progressionDTumorprogressionETumorregression第10題ThebasiccharacteristicsofchimericantigenreceptorTcelltherapy,except:()AMHC-restrictedBCAR-TtherapyisakindofadoptivecelltherapyCThemainsideeffectsincludecytokinereleasesyndromeandimmuneeffectorcell–associatedneurotoxicitysyndromeDneedtobindspecificsurfaceantigenontumorcellsECARshavebeendesignedusingreceptors,ligands,orscFvbindingdomains18.Cancerpaintherapytask第1題Whichofthefollowingisnotthecauseofcancerpain:()ATumorinvadesnerveBIntercostalnervepainafterlungcancersurgeryCHerpeszosterneuralgiaafterchemotherapyforlungcancerDPainaftertraumaEPleuriticpainafterradiotherapyforlungcancer第2題Whichofthefollowingisnotacancerpainassessmentprinciple:()ARegularBTakestheinitiativeCQuantizationDComprehensiveEDynamic第3題Amongthequantitativeassessmentmethodsofcancerpain,themostsuitableassessmentmethodforchildren,theelderlyandcommunicationdisorders:()ANRSBWongBakerCVASDVRSEBPI第4題Inthequantitativeassessmentmethodofcancerpain,whichisseverepainis:()ASleepismildlydisturbedBHaspainandcanliveanormallifeCSleepisnotdisturbedDSleepisoccasionallydisturbedESeverelydisturbedsleep正確答案：E第5題CancerpainassessmentNRSmethodbelongstoseverepainis:()A8B2C3D6E12第6題Whichofthefollowingisnotacancerpaintreatmentmethod:()AAntitumortherapyBOpioidtherapyCInterventionaltherapyDAntibiotictreatmentENSAIDtherapy第7題Whichofthefollowingdoesnotbelongtothethree-steptreatmentprincipleis:()AOraladministrationBDosingbyladderCDosingontimeDOn-demandadministrationEIndividualizeddrugdelivery第8題Inthethree-steptreatmentprincipleofcancerpain,severepainshouldbegiven:()ASingleuseofCelebrexBPregabalinaloneCCelebrex+PregabalinDTramadol+PregabalinEOxyContinorOxyContin+Celebrex正確答案：E第9題Whichofthefollowingarestrongopioidsis:()AFentanylBCelebrexCDexamethasoneDCodeineEPregabalin第10題Themostcommonlyusedmethodofadministrationaccordingtothethree-steptreatmentprincipleofcancerpainis:()ASubcutaneousBOrallyCVeinDIntramuscularinjectionEMucosaNutritiontherapyofcancertask第1題Whichofthefollowingstatementsisfalse?()ANutritionalsupportcanbegivenacrossthestepBEnteralnutritionsupplementationtakesprecedenceoverparenteralnutritionCNutritionalsupportshouldfollowindividualizedprinciplesDTwointolerancesmayoccurduringtotalenteralnutritiontherapy:gastricintoleranceandintestinalintoleranceEForpatientswithGItumors,parenteralnutritionshouldbepreferred正確答案：E第2題Nutritionalassessmentshouldbecompletedwithin()ofthepatient'sadmissionandperformedbyanutritionnurse,dietitianorphysician:()A24HoursB48HoursC14HoursD6HoursE36Hours第3題Whichofthefollowingisanutritionalinterventionthatallpatientswithmalnutrition(exceptthosewhocannotconsumefoodorally)shouldreceive:()AGastroenterostomyBjejunostomytubeCParenteralnutritionsupportDDiet+NutritionEducationEnone第4題IntheeventthattheTENdoesnotmeettherequirement,thechoiceshouldbe:()APEN+PPNBPENCPPNDONSEDiet+NutritionEducation第5題WhichofthefollowingisnotanindicationforTPN?()ALossofdigestivetractfunctionBNeedforintestinalrest:whenenteralnutritionc